ZA907641B - 4-substituted 2-aminoalk-3-enoic acids - Google Patents

4-substituted 2-aminoalk-3-enoic acids

Info

Publication number
ZA907641B
ZA907641B ZA907641A ZA907641A ZA907641B ZA 907641 B ZA907641 B ZA 907641B ZA 907641 A ZA907641 A ZA 907641A ZA 907641 A ZA907641 A ZA 907641A ZA 907641 B ZA907641 B ZA 907641B
Authority
ZA
South Africa
Prior art keywords
substituted
aliphatically
protected
amino
acylated
Prior art date
Application number
ZA907641A
Inventor
Christof Angst
Angst Christof
Roland Heckendorn
Heckendorn Roland
Hans Allgeier
Allgeier Hans
Daniel Wallach
Wallach Daniel
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of ZA907641B publication Critical patent/ZA907641B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3826Acyclic unsaturated acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/44Amides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/59Hydrogenated pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Substituted 2-aminoalk-3-enoic acid derivatives of the formula I <IMAGE> process for the preparation of unsaturated amino carboxylic acid derivatives of the formula I <IMAGE> in which R1 is an aliphatic or via a C atom bonded oxacycloaliphatic or optionally aliphatically N-substituted or N-acylated azacycloaliphatic hydrocarbon radical which is substituted by optionally acylated or aliphatically or araliphatically etherified hydroxyl, by halogen, by optionally acylated and/or aliphatically substituted amino or by an aza-, diaza-, azoxa- or oxacycloaliphatic radical, and R2 is free or esterified carboxyl, and their salts have a pronounced and selective antagonistic action on N-methyl-D-aspartic acid-sensitive (NMDA-sensitive) excitatory amino-acid receptors. They are prepared, for example, by, in a compound of the formula II <IMAGE> in which Z1, Z2 are optionally protected hydroxyl, Z3 is an aliphatic or via a C atom bonded oxacycloaliphatic or optionally protected or aliphatically N-substituted or N-acylated azacycloaliphatic hydrocarbon radical which is substituted by optionally protected or acylated or aliphatically or araliphatically etherified hydroxyl, by halogen, by optionally protected or acylated and/or aliphatically substituted amino or by an aza-, diaza-, azoxa- or oxacycloaliphatic radical, and Z4 is protected amino, converting protected amino Z4 and, where present, as component of Z3 into amino and, where present, protected hydroxyl Z1, Z2 and/or as component of Z3 into hydroxyl, and, where present, liberating a protected azacycloaliphatic hydrocarbon radical Z3 and, if required, converting a resulting compound into another compound of the formula I, fractionating a mixture of isomers obtainable according to the process into the components, and separating off the isomer which is preferred in each case, and/or converting a free compound obtainable according to the process into a salt or a salt obtainable according to the process into the corresponding free compound.
ZA907641A 1989-09-26 1990-09-25 4-substituted 2-aminoalk-3-enoic acids ZA907641B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH347989 1989-09-26

Publications (1)

Publication Number Publication Date
ZA907641B true ZA907641B (en) 1991-05-29

Family

ID=4256862

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA907641A ZA907641B (en) 1989-09-26 1990-09-25 4-substituted 2-aminoalk-3-enoic acids

Country Status (19)

Country Link
EP (1) EP0420806B1 (en)
JP (1) JPH03130296A (en)
KR (1) KR910006312A (en)
AT (1) ATE124700T1 (en)
AU (1) AU638057B2 (en)
CA (1) CA2026038A1 (en)
DD (1) DD298105A5 (en)
DE (1) DE59009368D1 (en)
DK (1) DK0420806T3 (en)
ES (1) ES2074153T3 (en)
FI (1) FI97231C (en)
HU (1) HUT56110A (en)
IE (1) IE67873B1 (en)
IL (1) IL95729A (en)
MX (1) MX22528A (en)
NO (1) NO179450C (en)
NZ (1) NZ235427A (en)
PT (1) PT95401B (en)
ZA (1) ZA907641B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0391850T3 (en) * 1989-04-07 1994-10-24 Ciba Geigy Ag Unsaturated aminodicarboxylic acid derivatives
GB9022785D0 (en) * 1990-10-19 1990-12-05 Merck Sharp & Dohme Therapeutic agents
US5464843A (en) * 1992-06-23 1995-11-07 G.D. Searle & Co. Imidazo[1,2-a]pyridinyldiacid compounds for cognitive enhancement and for treatment of cognitive disorders and neutrotoxic injury
WO2018193999A1 (en) * 2017-04-17 2018-10-25 国立大学法人京都大学 Optically-active 2-amino-phosphonoalkane acid, optically-active 2-amino-phosphonoalkane acid salt, and hydrates of these
EP3427729A1 (en) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid for use in treating epileptic diseases, disorders or conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0233154B1 (en) * 1986-02-13 1991-12-18 Ciba-Geigy Ag Unsaturated amino-acids
EP0302826A3 (en) * 1987-08-04 1991-04-03 Ciba-Geigy Ag Process for the preparation of unsaturated amino acid compounds

Also Published As

Publication number Publication date
NO179450B (en) 1996-07-01
IE67873B1 (en) 1996-05-01
IL95729A (en) 1998-02-22
HUT56110A (en) 1991-07-29
AU638057B2 (en) 1993-06-17
EP0420806B1 (en) 1995-07-05
DE59009368D1 (en) 1995-08-10
CA2026038A1 (en) 1991-03-27
DK0420806T3 (en) 1995-10-16
NO904169L (en) 1991-03-27
HU906210D0 (en) 1991-03-28
IL95729A0 (en) 1991-06-30
AU6315290A (en) 1991-04-11
FI97231B (en) 1996-07-31
IE903452A1 (en) 1991-04-10
NO179450C (en) 1996-10-09
EP0420806A1 (en) 1991-04-03
MX22528A (en) 1994-02-28
ATE124700T1 (en) 1995-07-15
FI97231C (en) 1996-11-11
DD298105A5 (en) 1992-02-06
ES2074153T3 (en) 1995-09-01
NO904169D0 (en) 1990-09-25
FI904690A0 (en) 1990-09-24
NZ235427A (en) 1992-10-28
JPH03130296A (en) 1991-06-04
PT95401A (en) 1991-05-22
PT95401B (en) 1997-07-31
KR910006312A (en) 1991-04-29

Similar Documents

Publication Publication Date Title
ES2044836T3 (en) DERIVED FROM PIPERIDINE, ITS USE AND PHARMACEUTICAL COMPOUND CONTAINING IT.
ATE127801T1 (en) PYRAZOLOPYRIDINE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF.
PT95281A (en) PROCESS FOR THE PREPARATION OF 4-BENZOYL-ISOXAZOLE DERIVATIVES AND HERBICIDAL COMPOSITIONS CONTAINING THEM
PT88944A (en) METHOD FOR PREPARING NEW BENZOCYCLETHENE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EP0230629A3 (en) 2-propylamino-tetralin derivatives for reducing intraocular pressure
DE60202906D1 (en) Solubilization of 1,3,5-triazine derivatives by means of esters of N-acylamino acids
AU638057B2 (en) 4-substituted 2-aminoalk-3-enoic acids
IE812974L (en) Tri-,tetra- and penta peptides
ES8600243A1 (en) Amide derivatives.
DK513080A (en) 6- (1-HYDROXYETHYL) -2- (2-AMINOETHYLTHIO) -1,1-DISUBSTITUTED 1-CARBADETHYAPEN-2-EM-3-CARBOXYLIC ACID AND PROCEDURE FOR PREPARING THEREOF
GR3018096T3 (en) Polypeptide comprising repeated cell-adhesive core sequences.
FI901709A (en) Process for the preparation of unsaturated aminodicarboxylic acid derivatives
JPS6466116A (en) Antiemetic containing specific substituted phenylalkylamino and amino acid derivatives and compound selected from other serotonin drying drugs
GR3002416T3 (en) Derivatives of glutamic acid, their salts, process for their preparation, use as medicines and compositions containing them
DK469285D0 (en) THIADIAZOLD DERIVATIVES AFFECTING THE CENTRAL NERVOUS SYSTEM, PROCEDURE FOR PREPARING THEREOF AND MENTALS CONTAINING THE DERIVATIVES
DE3770913D1 (en) CINNAMYLAMINE, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
ATE78250T1 (en) PROCESS FOR THE PREPARATION OF CHIRAL GLYCINE DERIVATIVES.
SE7509268L (en) PHENYLKETONES.
EA199700296A1 (en) DERIVATIVES 5H, 10H-IMIDAZO [1,2-a] INDENO [1,2-e] PIRAZIN-4-SHE, METHODS OF THEIR PRODUCTION, CONTAINING THEIR MEDICINE AND CONNECTIONS - INDANONA DERIVATIVE
ES8801291A1 (en) Cephalosporins, processes for their preparation and pharmaceutical compositions containing them.
RU94028711A (en) Derivatives of pyrrol-or pyrrolidin-2-boric acid, a mixture of their isomers or separate isomers and their salt and method of their production
TH591A (en) Process for the production of derivatives of 1-sulfo-2-acetidinone